Taiwan joined a small club of COVID-19 vaccine makers around the world on Monday, launching a new indigenous vaccine produced by Medigen Vaccine Biologics Corp.
On Monday (Aug 23), President Tsai Ing-wen was vaccinated with Taiwan’s first locally manufactured Covid-19 vaccine, providing her personal permission as the island prepares to give out the vaccine, whose approval opponents claim was hurried.
The health ministry approved the emergency use of Medigen Vaccine Biologics Corp’s Covid-19 vaccine last month as part of a bigger plan for inoculation self-sufficiency, following delays in vaccine supply from global drug corporations that have impacted Taiwan and many other countries.
Tsai, who had avoided utilising Moderna or AstraZeneca vaccinations, which are currently the foundation of Taiwan’s vaccination programme, received her Medigen shot at a hospital in central Taipei, confirming her faith in the vaccine’s safety.
Around 40% of Taiwan’s 23.5 million residents have gotten at least one dose of either the two-dose AstraZeneca or Moderna vaccinations, while just 5% are fully vaccinated.
However, unlike some other countries of Asia, Taiwan is not under any pressure to speed up its vaccine campaign because it only has a few home illnesses per day.